Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Conversation
The Conversation
Anna-Lise Williamson, Professor in Vaccinology, Institute of Infectious Disease and Molecular Medicine, University of Cape Town

Monkeypox vaccines: what's available and why they aren't a silver bullet

A dose of Imvanex vaccine used to protect against Monkeypox virus. Lex van Lieshout/ANP/AFP via Getty Images

In July 2022 the World Health Organization declared the recent current monkeypox outbreak a global health emergency. Since the start of the year thousands of cases have been reported from over 80 countries. The current outbreak is unlike any previous ones. Infections are happening in non-endemic countries outside of Africa. And the pattern is of sustained person-to-person transmission. But there has also been an increase in the number of cases in countries in west and central Africa where the disease is endemic. The current outbreak monkeypox virus strain has a relatively low mortality compared to other strains. If other strains escape Africa the problem is going to be far more challenging. The Conversation Africa spoke to virologist Anna-Lise Williamson about monkeypox vaccines and best way forward for African countries.


Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.